Du är här

2014-04-09

Analogic Corporation: Analogic Announces Agreement to Distribute Prostate Guidance Solution

Analogic to Offer D&K's BioJet Fusion System With Flex Focus Ultrasound for Precise, Targeted Prostate BiopsiesPEABODY, Mass., April 9, 2014 (GLOBE NEWSWIRE) --Analogic
Corporation(Nasdaq:ALOG), enabling the world's medical imaging and aviation
security technology, announced today that it has entered into a distribution
agreement with D&K Technologies, developer of the BioJet(TM) Solution, a
revolutionary 3D MRI transrectal ultrasound (TRUS) fusion technology.
Analogic will distribute the BioJet system for use with its BK Flex Focus(TM)
ultrasound systems, for assistance during precise, targeted prostate
biopsies, in Austria, Belgium, Denmark, Germany, Great Britain, Luxemburg,
North America, Sweden Switzerland, and The Netherlands.

The BioJet Fusion system overlays real-time ultrasound images from the BK Flex
Focus ultrasound system with MRI identified lesions to provide real-time
guidance during prostate biopsies. Analogic's European launch of this
advanced technology for MRI/ultrasound fusion guided biopsies will take place
at the 29thAnnual European Association of Urology (EAU) Congress in
Stockholm, Sweden, April 11-15.

"We are very excited to distribute the BioJet System by D&K Technologies, a
complementary combination of MRI for lesion visualization and real-time
ultrasound for enhanced biopsy guidance," said Farley Peechatka, senior vice
president and general manager of the Ultrasound Business at Analogic. "In
particular, the targeted biopsies will help to guide physicians to potential
regions of interest in the prostate that previously may have been missed.
Precise, targeted biopsies will potentially reduce the incidence of under-
and over-treatment of lesions."

The combination of the Flex Focus and BioJet offers a complete system that
will support both transperineal and transrectal biopsy methods. The BK
endocavity biplane transducer (8848) is ideal for transperineal fusion
biopsies. In addition, there are two options for transrectal fusion biopsies
- the BK triplane (8818) and BK biplane transducer (8808e). Data is easily
imported and exported allowing for a more convenient working process between
urologists and radiologists. Comprehensive biopsy reports contain fused MRI
and ultrasound images, and biopsy cores. The complete system is simple to use
with an intuitive user interface that includes easy contouring and
fine-tuning, designed specifically for busy urology practices. Finally, the
Flex Focus with the BioJet system has a small footprint, enabling it to fit
into tight spaces in a clinic or practice. For more information,
visit:www.analogicultrasound.com/fusion.

Background

According to researchers, the innovative fusion of MRI and ultrasound may be a
better way to detect and assess prostate cancer, while helping men avoid
unnecessary biopsies. This technology blends real-time imaging from MRI and
ultrasound devices, allowing physicians to more accurately direct the biopsy
needle that draws cell samples from suspected tumors. The technology is part
of an overall approach to use MRI scans to determine which men need to
undergo prostate biopsy and then use MRI/ultrasound fusion to perform the
most efficient biopsy possible. MRI is also used during the biopsy, whereby
an electromagnetic field generator is placed over the patient's hip, creating
real-time MRI images that are combined with ultrasound images to guide the
needle biopsy. The images from the earlier MRI screening can then be overlaid
with the real-time images to provide visible targets for the physician to
biopsy1.

According to the American Cancer Society, prostate cancer is the most common
cancer in American men other than skin cancer. It is estimated in 2014 that
approximately 233,000 new cases of prostate cancer will be diagnosed and
29,480 men will die of the disease2.

About Analogic

Analogic(Nasdaq:ALOG) provides leading-edge healthcare and security technology
solutions to advance the practice of medicine and save lives. We are
recognized around the world for advanced imaging systems and technology that
enable computed tomography (CT), ultrasound, digital mammography, and
magnetic resonance imaging (MRI), as well as automated threat detection for
aviation security. Our CT, MRI, digital mammography, and ultrasound
transducer products are sold to original equipment manufacturers (OEMs),
providing state-of-the-art capability and enabling them to enter new markets
and expand their existing market presence. Our market-leading BK Medical and
Ultrasonix branded ultrasound systems, used in procedure-driven markets such
as urology, surgery, and point-of-care, are sold to clinical end users
through our direct sales force. For over 40 years we've enabled customers to
thrive, improving the health and enhancing the safety of people around the
world. Analogic is headquartered just north of Boston, Massachusetts. For
more information, visitwww.analogic.com.

Analogic is a registered trademark of Analogic Corporation.

The globe logo is a trademark of Analogic Corporation.

1http://health.usnews.com/health-news/news/articles/2013/08/16/high-tech-...

2www.cancer.org/cancer/prostatecancer/detailedguide/prostate-cancer-key-s...

CONTACT: For Further Information, Contact:

Media Contact:
Amy Cook
(925) 552-7893
amycook@amcpublicrelations.com

Investor Contact:
Mark Namaroff
Director of Investor Relations
(978) 326-4058
investorrelations@analogic.com

---------------------------------------

This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Analogic Corporation via Globenewswire

HUG#1776169

Författare Hugin

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.